This book addresses the phenomenology, demographics, and neurobehavioral aspects of suicidal behavior and its risk factors, underscoring common neurobehavioral threads among different approaches which may underlie such extreme behavior. It additionally provides an overview of new approaches, such as imaging techniques to identify at-risk individuals or in response to drug treatment associated with suicidal behavior, neurodevelopmental approaches, genetic and epigenetic linkages to suicidal behavior, animal models of specific risk factors, as well as potential biomarkers being employed to help assess risk.
This book addresses the phenomenology, demographics, and neurobehavioral aspects of suicidal behavior and its risk factors, underscoring common neurobehavioral threads among different approaches which may underlie such extreme behavior. It additionally provides an overview of new approaches, such as imaging techniques to identify at-risk individuals or in response to drug treatment associated with suicidal behavior, neurodevelopmental approaches, genetic and epigenetic linkages to suicidal behavior, animal models of specific risk factors, as well as potential biomarkers being employed to help assess risk.
Explains the neurobehavioral basis of suicidal behavior Presents biomarkers for diagnosis as well as drug treatment opportunities Discusses how genetic and epigenetic factors influence suicidal behavior Includes supplementary material: sn.pub/extras
Keri E. Cannon
alcohol use drug treatment drug use imaging psychiatric disease suicadal behavior psychopharmacology
From the book reviews:
“This book, written and edited by researchers in the field, provides fairly comprehensive coverage … of the topic from the phenomenology to the neurobiology. … The target audience … includes psychiatrists, psychologists, mental health professionals, and researchers in the field.” (Michael Joel Schrift, Doody’s Book Reviews, February, 2015)